Short Interest in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Expands By 16.3%

by · The Cerbat Gem

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totalling 1,160,000 shares, an increase of 16.3% from the September 15th total of 997,700 shares. Currently, 2.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 358,600 shares, the days-to-cover ratio is currently 3.2 days.

Institutional Investors Weigh In On Aveanna Healthcare

Hedge funds have recently added to or reduced their stakes in the stock. Littlejohn & Co. LLC lifted its position in Aveanna Healthcare by 7.4% in the 1st quarter. Littlejohn & Co. LLC now owns 8,377,258 shares of the company’s stock valued at $20,859,000 after acquiring an additional 578,488 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Aveanna Healthcare by 1.8% during the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after acquiring an additional 44,970 shares during the last quarter. Acadian Asset Management LLC grew its position in shares of Aveanna Healthcare by 185.6% during the 1st quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock valued at $72,000 after acquiring an additional 19,096 shares during the period. Bank of New York Mellon Corp increased its stake in shares of Aveanna Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock worth $413,000 after purchasing an additional 9,243 shares in the last quarter. Finally, Renaissance Technologies LLC raised its holdings in Aveanna Healthcare by 155.8% in the 2nd quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after purchasing an additional 96,600 shares during the period. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Stock Up 1.8 %

Shares of NASDAQ:AVAH traded up $0.09 during trading on Monday, hitting $5.06. The stock had a trading volume of 168,913 shares, compared to its average volume of 186,934. The firm’s fifty day moving average is $5.05 and its 200 day moving average is $3.57. The company has a market capitalization of $973.44 million, a PE ratio of -8.48 and a beta of 2.12. Aveanna Healthcare has a 12 month low of $0.85 and a 12 month high of $5.95.

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. The business had revenue of $504.96 million during the quarter, compared to analysts’ expectations of $494.02 million. Equities research analysts expect that Aveanna Healthcare will post -0.09 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on AVAH shares. Deutsche Bank Aktiengesellschaft lifted their price target on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Royal Bank of Canada boosted their price objective on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “sector perform” rating in a research report on Friday, August 9th. Finally, UBS Group raised their target price on Aveanna Healthcare from $1.70 to $2.80 and gave the stock a “sell” rating in a research note on Friday, August 9th.

Get Our Latest Stock Report on AVAH

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

See Also